Released: March 30, 2013
F.D.A. approves a new diabetes drug from J.&J
Source: Katie Thomas and Andrew Pollak - The N.Y. Times ( Paid Registration )
The drug, Invokana, will be sold by Johnson & Johnson and treats patients with type 2 diabetes in a new way, by causing blood sugar to be excreted in the urine. Many existing drugs work by affecting the supply or use of insulin.
Read Full Article: F.D.A. approves a new diabetes drug from J.&J
Quick Menu
Support Consumer Action
Join Our Email List
Consumer Help Desk
- Help Desk
- Submit Your Complaints
- Presente su queja
- Frequently Asked Questions
- Links to Consumer Resources
- Consumer Service Guide (CSG)
- Alerts
- Consumer Booknotes